Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status

Sharon A McGrath-Morrow, Thomas Lauer, Michael Collaco, Armando Lopez, Deepti Malhotra, Yuriy O. Alekseyev, Enid Neptune, Robert A Wise, Shyam Biswal

Research output: Contribution to journalArticle

Abstract

Hyperoxia exposure can inhibit alveolar growth in the neonatal lung through induction of p21/p53 pathways and is a risk factor for the development of bronchopulmonary dysplasia (BPD) in preterm infants. We previously found that activation of nuclear factor erythroid 2 p45-related factor (Nrf2) improved survival in neonatal mice exposed to hyperoxia likely due to increased expression of anti-oxidant response genes. It is not known however, whether hyperoxic induced Nrf2 activation attenuates the growth impairment caused by hyperoxia in neonatal lung. To determine if Nrf2 activation modulates cell cycle regulatory pathway genes associated with growth arrest we examined the gene expression in the lungs of Nrf2-/- and Nrf2+/+ neonatal mice at one and 3days of hyperoxia exposure. Methods: Microarray analysis was performed in neonatal Nrf2+/+ and Nrf2-/- lungs exposed to one and 3days of hyperoxia. Sulforaphane, an inducer of Nrf2 was given to timed pregnant mice to determine if in utero exposure attenuated p21 and IL-6 gene expression in wildtype neonatal mice exposed to hyperoxia. Results: Cell cycle regulatory genes were induced in Nrf2-/- lung at 1day of hyperoxia. At 3days of hyperoxia, induction of cell cycle regulatory genes was similar in Nrf2+/+ and Nrf2-/- lungs, despite higher inflammatory gene expression in Nrf2-/- lung. Conclusion: p21/p53 pathways gene expression was not attenuated by Nrf2 activation in neonatal lung. In utero SUL did not attenuate p21 expression in wildtype neonatal lung exposed to hyperoxia. These findings suggest that although Nrf2 activation induces expression of anti-oxidant genes, it does not attenuate alveolar growth arrest caused by exposure to hyperoxia.

Original languageEnglish (US)
Pages (from-to)4-9
Number of pages6
JournalCytokine
Volume65
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Hyperoxia
Gene expression
Genes
Chemical activation
Lung
Cells
Oxidants
cdc Genes
Regulator Genes
Gene Expression
Microarrays
Growth
Interleukin-6
Bronchopulmonary Dysplasia
p53 Genes
Microarray Analysis
Premature Infants

Keywords

  • Alveolar growth inhibition
  • Cell cycle regulatory genes
  • Chronic lung disease of prematurity
  • Hyperoxia
  • Inflammation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology
  • Biochemistry
  • Molecular Biology

Cite this

Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status. / McGrath-Morrow, Sharon A; Lauer, Thomas; Collaco, Michael; Lopez, Armando; Malhotra, Deepti; Alekseyev, Yuriy O.; Neptune, Enid; Wise, Robert A; Biswal, Shyam.

In: Cytokine, Vol. 65, No. 1, 01.2014, p. 4-9.

Research output: Contribution to journalArticle

@article{5e7472b5b5f64ab5a52fc1b3e544437b,
title = "Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status",
abstract = "Hyperoxia exposure can inhibit alveolar growth in the neonatal lung through induction of p21/p53 pathways and is a risk factor for the development of bronchopulmonary dysplasia (BPD) in preterm infants. We previously found that activation of nuclear factor erythroid 2 p45-related factor (Nrf2) improved survival in neonatal mice exposed to hyperoxia likely due to increased expression of anti-oxidant response genes. It is not known however, whether hyperoxic induced Nrf2 activation attenuates the growth impairment caused by hyperoxia in neonatal lung. To determine if Nrf2 activation modulates cell cycle regulatory pathway genes associated with growth arrest we examined the gene expression in the lungs of Nrf2-/- and Nrf2+/+ neonatal mice at one and 3days of hyperoxia exposure. Methods: Microarray analysis was performed in neonatal Nrf2+/+ and Nrf2-/- lungs exposed to one and 3days of hyperoxia. Sulforaphane, an inducer of Nrf2 was given to timed pregnant mice to determine if in utero exposure attenuated p21 and IL-6 gene expression in wildtype neonatal mice exposed to hyperoxia. Results: Cell cycle regulatory genes were induced in Nrf2-/- lung at 1day of hyperoxia. At 3days of hyperoxia, induction of cell cycle regulatory genes was similar in Nrf2+/+ and Nrf2-/- lungs, despite higher inflammatory gene expression in Nrf2-/- lung. Conclusion: p21/p53 pathways gene expression was not attenuated by Nrf2 activation in neonatal lung. In utero SUL did not attenuate p21 expression in wildtype neonatal lung exposed to hyperoxia. These findings suggest that although Nrf2 activation induces expression of anti-oxidant genes, it does not attenuate alveolar growth arrest caused by exposure to hyperoxia.",
keywords = "Alveolar growth inhibition, Cell cycle regulatory genes, Chronic lung disease of prematurity, Hyperoxia, Inflammation",
author = "McGrath-Morrow, {Sharon A} and Thomas Lauer and Michael Collaco and Armando Lopez and Deepti Malhotra and Alekseyev, {Yuriy O.} and Enid Neptune and Wise, {Robert A} and Shyam Biswal",
year = "2014",
month = "1",
doi = "10.1016/j.cyto.2013.09.021",
language = "English (US)",
volume = "65",
pages = "4--9",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status

AU - McGrath-Morrow, Sharon A

AU - Lauer, Thomas

AU - Collaco, Michael

AU - Lopez, Armando

AU - Malhotra, Deepti

AU - Alekseyev, Yuriy O.

AU - Neptune, Enid

AU - Wise, Robert A

AU - Biswal, Shyam

PY - 2014/1

Y1 - 2014/1

N2 - Hyperoxia exposure can inhibit alveolar growth in the neonatal lung through induction of p21/p53 pathways and is a risk factor for the development of bronchopulmonary dysplasia (BPD) in preterm infants. We previously found that activation of nuclear factor erythroid 2 p45-related factor (Nrf2) improved survival in neonatal mice exposed to hyperoxia likely due to increased expression of anti-oxidant response genes. It is not known however, whether hyperoxic induced Nrf2 activation attenuates the growth impairment caused by hyperoxia in neonatal lung. To determine if Nrf2 activation modulates cell cycle regulatory pathway genes associated with growth arrest we examined the gene expression in the lungs of Nrf2-/- and Nrf2+/+ neonatal mice at one and 3days of hyperoxia exposure. Methods: Microarray analysis was performed in neonatal Nrf2+/+ and Nrf2-/- lungs exposed to one and 3days of hyperoxia. Sulforaphane, an inducer of Nrf2 was given to timed pregnant mice to determine if in utero exposure attenuated p21 and IL-6 gene expression in wildtype neonatal mice exposed to hyperoxia. Results: Cell cycle regulatory genes were induced in Nrf2-/- lung at 1day of hyperoxia. At 3days of hyperoxia, induction of cell cycle regulatory genes was similar in Nrf2+/+ and Nrf2-/- lungs, despite higher inflammatory gene expression in Nrf2-/- lung. Conclusion: p21/p53 pathways gene expression was not attenuated by Nrf2 activation in neonatal lung. In utero SUL did not attenuate p21 expression in wildtype neonatal lung exposed to hyperoxia. These findings suggest that although Nrf2 activation induces expression of anti-oxidant genes, it does not attenuate alveolar growth arrest caused by exposure to hyperoxia.

AB - Hyperoxia exposure can inhibit alveolar growth in the neonatal lung through induction of p21/p53 pathways and is a risk factor for the development of bronchopulmonary dysplasia (BPD) in preterm infants. We previously found that activation of nuclear factor erythroid 2 p45-related factor (Nrf2) improved survival in neonatal mice exposed to hyperoxia likely due to increased expression of anti-oxidant response genes. It is not known however, whether hyperoxic induced Nrf2 activation attenuates the growth impairment caused by hyperoxia in neonatal lung. To determine if Nrf2 activation modulates cell cycle regulatory pathway genes associated with growth arrest we examined the gene expression in the lungs of Nrf2-/- and Nrf2+/+ neonatal mice at one and 3days of hyperoxia exposure. Methods: Microarray analysis was performed in neonatal Nrf2+/+ and Nrf2-/- lungs exposed to one and 3days of hyperoxia. Sulforaphane, an inducer of Nrf2 was given to timed pregnant mice to determine if in utero exposure attenuated p21 and IL-6 gene expression in wildtype neonatal mice exposed to hyperoxia. Results: Cell cycle regulatory genes were induced in Nrf2-/- lung at 1day of hyperoxia. At 3days of hyperoxia, induction of cell cycle regulatory genes was similar in Nrf2+/+ and Nrf2-/- lungs, despite higher inflammatory gene expression in Nrf2-/- lung. Conclusion: p21/p53 pathways gene expression was not attenuated by Nrf2 activation in neonatal lung. In utero SUL did not attenuate p21 expression in wildtype neonatal lung exposed to hyperoxia. These findings suggest that although Nrf2 activation induces expression of anti-oxidant genes, it does not attenuate alveolar growth arrest caused by exposure to hyperoxia.

KW - Alveolar growth inhibition

KW - Cell cycle regulatory genes

KW - Chronic lung disease of prematurity

KW - Hyperoxia

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84888200229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888200229&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2013.09.021

DO - 10.1016/j.cyto.2013.09.021

M3 - Article

VL - 65

SP - 4

EP - 9

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 1

ER -